|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 39/395 | |
| A61P 35/00 | |||
| C07K 16/24 | |||
| C07K 16/46 |
| (11) | Number of the document | 1711528 |
| (13) | Kind of document | T |
| (96) | European patent application number | 04815598.0 |
| Date of filing the European patent application | 2004-12-23 | |
| (97) | Date of publication of the European application | 2006-10-18 |
| (45) | Date of publication and mention of the grant of the patent | 2012-07-18 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2004/043541 |
| Date | 2004-12-23 |
| (87) | Number | WO 2005/062972 |
| Date | 2005-07-14 |
| (30) | Number | Date | Country code |
| 532130 P | 2003-12-23 | US |
| (72) |
FUNG, Sek, Chung, US
MOYLE, Matthew, US
|
| (73) |
Genentech, Inc.,
1 DNA Way, South San Francisco, CA 94080,
US
|
| (54) | TREATMENT OF CANCER WITH NOVEL ANTI-IL 13 MONOCLONAL ANTIBODIES |
| TREATMENT OF CANCER WITH NOVEL ANTI-IL 13 MONOCLONAL ANTIBODIES |